Abstract
Objective The aim of this study was to evaluate medication use pattern in a university tertiary hospital in the Sultanate of Oman. Setting The study was conducted at the Sultan Qaboos University Hospital (SQUH) and the SQUH Family and Community Medicine clinic (FAMCO), Muscat, Sultanate of Oman during 7th to 25th June 2008. Method The medication use pattern was evaluated in women attending FAMCO and the standard antenatal clinics at the hospital. Women were interviewed in different gestational ages using a structured questionnaire. The Electronic Patient Record (EPR) was reviewed to acquire additional information on medication use. Medications were classified according to the US FDA risk classification. Main outcome measure Medication used including prescribed medications, OTC medications, or herbal treatment during the current pregnancy and 3 months prior to conception. Results The study included a total of 139 pregnant mothers with an overall mean age of 28 ± 5 years ranging from 19 to 45 years. There was a slight overall reduction in the medication use including prescribed medications. However, there was a significant increase in utilization of vitamins and supplements (84–95% vs. 12% in the 3-months prior, P < 0.001) as well as herbal preparations (16–19% vs. 7% in the 3-months prior, P = 0.011) throughout pregnancy (P < 0.010). The use of category A medications increased in all trimester (43–52% vs. 13% in the 3 months prior, P < 0.010) while a reduction in the use of category C (for first and third trimester, P < 0.050) and D medications was seen. A reduction in the use of teratogenic drugs in all trimesters (P < 0.010) was also observed. Conclusion The prescribing of vitamins and minerals was optimal. However, the common use of herbal supplements observed warrants special attention due to their unknown risks. The conclusions should be interpreted in light of the study’s limitations
Similar content being viewed by others
References
Kacew S. Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy. Int J Clin Pharmacol Ther. 1994;32(7):335–43.
Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338(16):1128–37.
Berglund F, Flodh H, Lundborg P, Prame B, Sannerstedt R. Drug use during pregnancy and breast-feeding. A classification system for drug information. Acta Obstet Gynecol Scand Suppl. 1984;126:1–55.
Australian Drug Evaluation Committee. Prescribing medicines in pregnancy. 4th ed. Woden, Australia: Aust Gov Pub Unit; 1999.
Food and Drug Administration. Requirements on content and format of labeling for human prescription drug and biological products. Fed Regist. 2006;71:3921–97.
Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, Xue Z. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf. 2006;15(8):537–45.
Henry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol. 2000;40(2):165–72.
Headley J, Northstone K, Simmons H, Golding J, the ALSPAC Study Team. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol. 2004;60:355–61.
Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000;356:1735–6.
Olesen C, Sorensen HT, den Berg L, Olsen J, Steffensen FH, the Euromap Group. Prescribing during pregnancy and lactation with reference to the Swedish classification system: a population-based study among Danish women. Acta Obstet Gynecol Scand. 1999;78:686–92.
Rohra DK, Das N, Azam SI, Solangi NA, Memon Z, Shaikh AM, Khan NH. Drug prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study. BMC Pregnancy Childbirth. 2008;8:24.
Sharma R, Kapoor B, Verma U. Drug utilization pattern during pregnancy in North India. Indian J Med Sci. 2006;60:277–87.
Al-Humayyd MS, Babay ZH. Pattern of drug prescribing during pregnancy in Saudi women: a retrospective study. Saudi Pharm J. 2006;14(3,4):201–7.
Lexi-Drugs Online [database on the Internet]. Hudson, OH: Lexi-Comp, Inc.; 2008 [cited 30 July 2008]. Available from: http://online.lexi.com. Subscription required to view.
Briggs GG, Freeman RK, Summer JY. Drugs in pregnancy and lactation. 6th ed. Baltimore: Williams and Wilkins; 2002.
StataCorp. Stata: Release 11.1. Statistical Software. College Station, TX: StataCorp LP; 2010.
Tilley BC, Barnes AB, Bergstralh E, Labarthe D, Noller KL, Colton T, Adam E. A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol. 1985;121(2):269–81.
Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sřensen HT, the EuroMAP Group. Recall bias in a casecontrol surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12:461–6.
Bryant HE, Visser N, Love EL. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and postnatal women. Am J Public Health. 1989;79:78–80.
Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123:670–6.
Forfar JO, Nelson MM. Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely. Clin Pharmacol Ther. 1973;14:632–42.
Hassan AS, Al-Kharusi BM. Knowledge and use of folic acid among pregnant Arabian women residing in Qatar and Oman. Int J Food Sci Nutr. 2008;59(1):70–9.
Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191:398.
Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006;6:21.
Byrne MJ, Semple SJ, Coulthard KP. Complementary medicine use during pregnancy. Interviews with 48 women in a hospital antenatal ward. Aust Pharmacist. 2002;21:954–9.
Hepner DL, Harnett M, Segal S, Camann W, Bader A, Tsen L. Herbal use in parturients. Anesth Analg. 2002;94:690–3.
Hollyer T, Boon H, Georgousis A, Smith M, Einarson A. The use of CAM by women suffering from nausea and vomiting during pregnancy. BMC Complement Altern Med. 2002;2(1):5.
Acknowledgments
We would like to thank the women who participated in the study, to the Pharmacy and the Obstetric/Gynecology departments who provided their support to this study.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Riyami, I.M., Al-Busaidy, I.Q. & Al-Zakwani, I.S. Medication use during pregnancy in Omani women. Int J Clin Pharm 33, 634–641 (2011). https://doi.org/10.1007/s11096-011-9517-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-011-9517-y